Parkinson's Disease in Traditional Chinese and Western Medicine: A Review
DOI:
https://doi.org/10.53469/jcmp.2024.06(11).15Keywords:
Parkinson's disease, Traditional Chinese and western medicine, Progress, ReviewAbstract
Parkinson's disease (PD) is a neurodegenerative disease that seriously endangers the health of the middle-aged and elderly people. The main clinical manifestations include motor symptoms such as bradykinesia, static tremor, and myotonia and non-motor symptoms like constipation, mental disorders, sleep disorders, and autonomic nervous dysfunction. Its etiology and pathogenesis have not been fully understood, and the clinical efficacy is not satisfactory. By searching the relevant literature in China and abroad in recent years, this paper summarized the etiology, pathogenesis, and treatment of PD in both traditional Chinese medicine (TCM) and western medicine as well as the integrated TCM and Western medicine treatment.
References
Luo Xiaodong, Li Zhe, Zhu Meiling, etc. Expert Consensus on Clinical Diagnosis and Treatment of Parkinson's Disease [J]. Journal of Traditional Chinese Medicine, 2021, 62 (23): 2109-2116.
Huang Zhilan, Zhao Yang. The present situation and prospect of traditional Chinese medicine in the treatment of Parkinson's disease [J]. Integrated Chinese and Western Medicine Journal of Cardiovascular and Cerebrovascular Diseases, 2013, v. 11 (01): 81-83.
Niu Liyun, He Jiani, Zhang Ding, Feng Weixing. Pathogenesis of Parkinson's disease and acupuncture treatment progress [J]. Journal of Liaoning University of Traditional Chinese Medicine, 2022, 24 (04): 217-220.
Wang Jiabin, Shen Xiaoming, Ma Yunzhi, Su Chaoyang, Bian Songbo. Advances in Chinese and Western Medicine Research of Parkinson's Disease [J]. Chinese Journal of Experimental Prescriptions, 2022, v. 28 (01): 241-250.
ROCHA E M, DE MIRANDA B, SANDERS L H. Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease[J]. Neurobiol Dis, 2018, 109(Pt B):249-257.
RYAN B J, HOEK S, FON E A, et al. Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease[J]. Trends Biochem Sci, 2015, 40(4):200-210.
ZHU Z, YANG C B, IYASWAMY A, et al. Balancing mTOR signaling and autophagy in the treatment of Parkinson's disease[J]. Int J Mol Sci, 2019, 20(3):728.
SHEIKH A, SHEIKH K. The expression change of glial fibrillary acidic protein and tyrosine hydroxylase in substantia nigra of the Wistar rats exposed to chlorpyrifos: a novel environmental risk factor for Parkinson's disease[J]. Experimental Brain Research, 2020, 238(9):2041-2051.
Sun Qiaojie. Western medicine combined with Ziyang Shujin Decoction in the treatment of 28 cases of Parkinson's movement disorder [J]. Chinese folk medicine, 2017, 26 (18): 121-122.
Xiao Gaiqin, Zhang Kexun. The clinical effect of Huangqi Bushen Decoction combined with acupuncture in the treatment of Parkinson's disease [J]. Clinical medical research and practice, 2018, 3 (25): 122-123.
Wang Wei, Li Wentao, Li Rukui. Clinical study of Zhichan Decoction in the treatment of Parkinson's disease with anxiety and depression [J]. Integrated Chinese and Western Medicine Cardiovascular and Cerebrovascular Journal, 2018, 16 (17): 2556-2558.
Dong Lihua, Hu Guohua, Wang Yushan, et al. A clinical study of dopamine receptor agonists in the treatment of early Parkinson's disease [J]. Clinical meta-analysis, 2006, 21 (13): 959-960.
Zis P, Martinez-Martin P, Sauerbier A, et al. Non-motor symptoms burden in treated and untreated early Parkinson's disease patients: Argument for non-motor subtypes[J]. Eur J Neurol, 2015, 22(8):1145-1150.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Zhenbei Zhao, Xiaoyan Wang
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
